✦ LIBER ✦
PRS40 THE IMPACT OF THE FDA'S RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
✍ Scribed by Horowicz-Mehler, N; Sepulveda, B; White, C; Doyle, J
- Book ID
- 121954152
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 68 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.